您现在位置：健康网-医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告

Drugs for Hepatopathy Report

健康网讯：

Market Research Report on Drugs for Hepatopathy 

Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published: 
Format:  Hardcopy and Adobe PDF 
Price:  US$6,000 
Contact: Mr. Bian chenghua   Ms. Wu huifang
Tel.: 86-10-68012929-2116/2101             Fax:  86-10-68012929-2008
E-mail: bianch@healthoo.com   wuhf@healthoo.com                      
http://www.healthoo.com

Table of contents
1 Categories of Hepatopathy and epidemiology
  1.1 virus hepatitis
  1.2 hepatocirrhosis
  1.3 fatty liver
  1.4 alcoholic liver disease

2 Familiar drugs for Hepatopathy
  2.1 antiviral drugs
    2.1.1 Interferon
    2.1.2 Nucleoside analog
    2.1.3 Kushenin
  2.2 Immune regulator
  2.3 Drugs for hepatic coma
  2.4 Adjunct drugs for Hepatopathy
  2.5 Chinese traditional medicine
3. Market scale and sales analysis of hospital market
  3.1 Market scale and growth trend
    3.1.1 Market scale of retail and hospital market last year
    3.1.2 Growth trend of different categories in the past few years
    3.1.3 Breeds with sales going up(or down) 
    3.1.4 Market shares of joint venture, foreign, joint venture
 enterprises
  3.2 Hospital market shares of different breeds in sample cities
 last year
    3.2.1 Beijing
    3.2.2 Guangzhou
    3.2.3 Shanghai
  3.3 Sales analysis of key breeds
    3.3.1 ribonucleic acid（RNA）
    3.3.2 Compound glycyrrhizin
    3.3.3 Kushenin
    3.3.4 YinZhiHuang solution for injection
    3.3.5 diammonium glycyrrhizinate
  3.4 Others
    3.4.1 Lamivudine
    3.4.2 hepatic vaccine 
4 Sales analysis of retail market for protecting liver
  4.1 Change trend of monthly sales
  4.2 Sales analysis of sample pharmacies
    4.2.1 Market share of chemical drugs
    4.2.2 Market share of Chinese traditional medicine
  4.3 Region sales of key breeds
  4.4 Retail analysis of pharmacies in Beijing, Guangzhou, Shenzhen